Skip to main content

Table 1 Patients baseline characteristics

From: Outcomes and prognostic factors of patients treated for in-stent restenosis: a retrospective single-center experience

Characteristics

Total n = 116 (%)

Sex, male

86 (74%)

Cardiovascular risk factors

 

 Diabetes mellitus

64 (55.2%)

 Hypertension

72 (62.1%)

 Smoking (or stopped for less than 3 years)

70 (60.3%)

 LDL-cholesterol > 1.41 mmol/l

50 (43.9%)

 Family history of coronary artery disease

13 (11.2%)

Comorbidities

 

 Chronic kidney disease (creatinine clearance < 60 ml/min)

47 (40.5%)

 Heart failure

9 (7.7%)

Statins therapy

 

 High-dose statins therapy*

32 (27.6%)

  1. LDL low-density lipoprotein, LVEF left ventricular ejection fraction
  2. *Atorvastatin 80 mg once daily or Rosuvastatin 20 mg once daily